Advertisement
Advertisement
OGI
Organigram Global Inc. Common Shares
1.39
USDSponsored
-0.04
-3.15%
Mar 18, 14:53 UTC -4
Closed
Pre-Market
1.39
0.00
0.00%
OGI Earnings Reports
Positive Surprise Ratio
OGI beat 18 of 38 last estimates.
47%
Next Report
Date of Next Report
May 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
$72.33M
/-$0.01
Implied change from Q1 26 (Revenue/ EPS)
+13.84%
/-107.14%
Implied change from Q2 25 (Revenue/ EPS)
+10.26%
/-103.03%
Organigram Global Inc. Common Shares earnings per share and revenue
On Feb 10, 2026, OGI reported earnings of 0.14 USD per share (EPS) for Q1 26, beating the estimate of -0.01 USD, resulting in a 1486.14% surprise. Revenue reached 63.54 million, compared to an expected 73.88 million, with a -14.00% difference. The market reacted with a -12.58% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 72.33 million USD, implying an decrease of -107.14% EPS, and increase of 13.84% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.26
Surprise
+98.02%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
Exagen Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-4.22%
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were Organigram Global Inc. Common Shares's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Organigram Global Inc. Common Shares reported EPS of $0.14, beating estimates by 1486.14%, and revenue of $63.54M, -14% below expectations.
How did the market react to Organigram Global Inc. Common Shares's Q1 2026 earnings?
The stock price moved down -12.58%, changed from $1.59 before the earnings release to $1.39 the day after.
When is Organigram Global Inc. Common Shares expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Organigram Global Inc. Common Shares's next earnings report?
Based on 3
analysts, Organigram Global Inc. Common Shares is expected to report EPS of -$0.01 and revenue of $72.33M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement